NCT00047528

Brief Summary

To compare intraocular pressure lowering effectiveness of a combination drug vs. two individual drugs dosed alone.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Jan 2001

Typical duration for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2001

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

October 8, 2002

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 18, 2002

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2003

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2003

Completed
Last Updated

August 5, 2008

Status Verified

August 1, 2008

Enrollment Period

2.8 years

First QC Date

October 8, 2002

Last Update Submit

August 4, 2008

Conditions

Open-Angle GlaucomaOcular Hypertension

Keywords

open-angleglaucomaocularhypertensionPOAG

Interventions

Alcon Investigational AgentDRUG

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Adult subjects of either sex and any race with open-angle glaucoma or ocular hypertension; visual acuity of 20/80 to 20/400 or better (Snellen equivalent) or logMAR visual acuity not worse than 0.6. Clinically relevant ophthalmic or systemic conditions may be excluded.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Clinical Trial Sites

Fort Worth, Texas, 76134, United States

Location

MeSH Terms

Conditions

Glaucoma, Open-AngleOcular HypertensionGlaucomaHypertension

Condition Hierarchy (Ancestors)

Eye DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

October 8, 2002

First Posted

October 18, 2002

Study Start

January 1, 2001

Primary Completion

November 1, 2003

Study Completion

November 1, 2003

Last Updated

August 5, 2008

Record last verified: 2008-08

Locations

US(1)